Drug Name |
Drug ID |
Indication |
Formulation Name |
Formulation ID |
Atovaquone
|
DMY4UMW
|
Fungal infection [1F29-1F2F] |
Atovaquone 750mg/5ml suspension |
F24252
|
Azelaic Acid
|
DMHVL0J
|
Acne vulgaris [ED80] |
Azelaic Acid 15% aerosol |
F23631
|
Ceftibuten
|
DMWV2AG
|
Acute otitis media [AB00] |
Ceftibuten Dihydrate eq 400mg base capsule |
F23339
|
Eltrombopag
|
DMOGFIX
|
Thrombocytopenia [3B64] |
Eltrombopag Olamine eq 12.5mg acid/packet for suspension |
F23959
|
Famotidine
|
DMRL3AB
|
Gastric ulcer [DA60] |
Famotidine 40mg/5ml for suspension |
F23511
|
Mirabegron
|
DMS1GYT
|
Overactive bladder [GC50.0] |
Mirabegron 8mg/ml extended release for suspension |
F23820
|
Mupirocin
|
DMWX683
|
Bacterial infection [1A00-1C4Z] |
Mupirocin eq 2% base cream |
F23827
|
Ribociclib Succinate
|
DM9CIUW
|
Breast cancer [2C60-2C65] |
Ribociclib Succinate 200mg tablet |
F23272
|
Siponimod
|
DM2R86O
|
Multiple sclerosis [8A40] |
Siponimod 0.25mg tablet |
F23895
|
Sulfacetamide
|
DMZ6VEY
|
Acne vulgaris [ED80] |
Sulfacetamide 10% cream |
F23909
|
------------------ |
|
|
|
|